UNSPSC 51142529: Lazabemide

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51142529

Definition

This classification denotes a monoamine oxidase inhibitor with the molecular formula C8H10ClN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 420HD787N9, chemically known as 2-pyridinecarboxamide, n-(2-aminoethyl)-5-chloro- but generally known as lazabemide, which bears US NIH Compound Identifier 71307. European Medicines Agency schedules Lazabemide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08418MIG. The term LAZABEMIDE is an International Non-Proprietary Name.

Read the full definition

LAZABEMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lazabemide under HS 29333999 and SITC 51574. As of Q4 2014, LAZABEMIDE remains the US FDA Preferred Term for this commodity. Lazabemide bears US NLM identifiers UMLS ID C0209106 and NCI Concept Code C80964. SMILES: CLC1CCC(NC1)C(=O)NCCN.

About UNSPSC 51142529

UNSPSC 51142529 Lazabemide is a Commodity code that maps to pharmaceutical procurement, though the recent state and local activity tagged under it shows a mismatch with the code's narrow nominal scope. The single recent opportunity—Seminole County, Florida's IFB for naloxone and drug deactivation systems—reflects broader public health and emergency-response pharmaceutical acquisition rather than lazabemide-specific procurement. State and local governments use codes in this family to source emergency medications, overdose-reversal agents, and related medical supplies through competitive bidding processes to support community health and harm-reduction initiatives. Issuing bodies include county health departments and community health programs that source these supplies on recurring, multi-year contracts with quarterly or routine delivery schedules.

Seminole County, Florida represents the documented geographic activity for this code in the recent opportunity record. The county released IFB 60459723LAS on June 30, 2026, seeking annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with a response deadline of July 26, 2026, at 2:00 pm. Quarterly deliveries flow to the Seminole County Community Health Building in Sanford, Florida. Vendors must submit bids electronically through the county's e-procurement portal, include all shipping and delivery costs in their proposal, and comply with drug-free workplace certification, E-Verify requirements, and standard insurance coverage mandates. The contract term runs two years with a one-year renewal option and includes a three-month probationary termination clause. FEMA funding introduces federal compliance overlays including Clean Air Act and Federal Water Pollution Control Act adherence, though the procurement carries no explicit set-aside designations for disadvantaged enterprises.

Quick answers

What is UNSPSC 51142529?

UNSPSC 51142529 is Lazabemide, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51142529?

UNSPSC 51142529 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51142529

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code